These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3246034)

  • 21. Studies on the mechanism of toxicity of acetaminophen. Synthesis and reactions of N-acetyl-2,6-dimethyl- and N-acetyl-3,5-dimethyl-p-benzoquinone imines.
    Fernando CR; Calder IC; Ham KN
    J Med Chem; 1980 Nov; 23(11):1153-8. PubMed ID: 7452663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxic effects of N-acetyl-p-benzoquinone imine, a common arylating intermediate of paracetamol and N-hydroxyparacetamol.
    Holme JA; Dahlin DC; Nelson SD; Dybing E
    Biochem Pharmacol; 1984 Feb; 33(3):401-6. PubMed ID: 6704159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of N-acetyl-p-benzoquinone imine cytotoxicity.
    Albano E; Rundgren M; Harvison PJ; Nelson SD; Moldéus P
    Mol Pharmacol; 1985 Sep; 28(3):306-11. PubMed ID: 4033631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The acetaminophen metabolite N-acetyl-p-benzoquinone imine (NAPQI) inhibits glutathione synthetase in vitro; a clue to the mechanism of 5-oxoprolinuric acidosis?
    Walker V; Mills GA; Anderson ME; Ingle BL; Jackson JM; Moss CL; Sharrod-Cole H; Skipp PJ
    Xenobiotica; 2017 Feb; 47(2):164-175. PubMed ID: 27086508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivation of glyceraldehyde-3-phosphate dehydrogenase by a reactive metabolite of acetaminophen and mass spectral characterization of an arylated active site peptide.
    Dietze EC; Schäfer A; Omichinski JG; Nelson SD
    Chem Res Toxicol; 1997 Oct; 10(10):1097-103. PubMed ID: 9348431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-hydroxyacetaminophen: a postulated toxic metabolite of acetaminophen.
    Calder IC; Hart SJ; Healey K; Ham KN
    J Med Chem; 1981 Aug; 24(8):988-93. PubMed ID: 7328601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of acetaminophen-reactive metabolite formation by methylxanthines and known cytochrome P-450 activators.
    Lee CA; Thummel KE; Kalhorn TF; Nelson SD; Slattery JT
    Drug Metab Dispos; 1991; 19(5):966-71. PubMed ID: 1686244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites.
    Senter PD; Al-Abed Y; Metz CN; Benigni F; Mitchell RA; Chesney J; Han J; Gartner CG; Nelson SD; Todaro GJ; Bucala R
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):144-9. PubMed ID: 11773615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults.
    Thummel KE; Slattery JT; Ro H; Chien JY; Nelson SD; Lown KE; Watkins PB
    Clin Pharmacol Ther; 2000 Jun; 67(6):591-9. PubMed ID: 10872641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunochemical analysis of acetaminophen covalent binding to proteins. Partial characterization of the major acetaminophen-binding liver proteins.
    Bartolone JB; Birge RB; Sparks K; Cohen SD; Khairallah EA
    Biochem Pharmacol; 1988 Dec; 37(24):4763-74. PubMed ID: 3060126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of acetaminophen (APAP)-induced hepatotoxicity by leflunomide via inhibition of APAP biotransformation to N-acetyl-p-benzoquinone imine.
    Tan SC; New LS; Chan EC
    Toxicol Lett; 2008 Aug; 180(3):174-81. PubMed ID: 18588957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4.
    Thummel KE; Lee CA; Kunze KL; Nelson SD; Slattery JT
    Biochem Pharmacol; 1993 Apr; 45(8):1563-9. PubMed ID: 8387297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enzymatic and non-enzymatic reduction of N-acetyl-p-benzoquinone imine and some properties of the N-acetyl-p-benzosemiquinone imine radical.
    Powis G; Svingen BA; Dahlin DC; Nelson SD
    Biochem Pharmacol; 1984 Aug; 33(15):2367-70. PubMed ID: 6087825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation.
    Manyike PT; Kharasch ED; Kalhorn TF; Slattery JT
    Clin Pharmacol Ther; 2000 Mar; 67(3):275-82. PubMed ID: 10741631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Horseradish peroxidase-catalyzed oxidation of acetaminophen to intermediates that form polymers or conjugate with glutathione.
    Potter DW; Miller DW; Hinson JA
    Mol Pharmacol; 1986 Feb; 29(2):155-62. PubMed ID: 3951429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acetaminophen-induced liver injury in obesity and nonalcoholic fatty liver disease.
    Michaut A; Moreau C; Robin MA; Fromenty B
    Liver Int; 2014 Aug; 34(7):e171-9. PubMed ID: 24575957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fennel and raspberry leaf as possible inhibitors of acetaminophen oxidation.
    Langhammer AJ; Nilsen OG
    Phytother Res; 2014 Oct; 28(10):1573-6. PubMed ID: 24458977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that acetaminophen and N-hydroxyacetaminophen form a common arylating intermediate, N-acetyl-p-benzoquinoneimine.
    Corcoran GB; Mitchell JR; Vaishnav YN; Horning EC
    Mol Pharmacol; 1980 Nov; 18(3):536-42. PubMed ID: 7464816
    [No Abstract]   [Full Text] [Related]  

  • 39. Protein and nonprotein cysteinyl thiol modification by N-acetyl-p-benzoquinone imine via a novel ipso adduct.
    Chen W; Shockcor JP; Tonge R; Hunter A; Gartner C; Nelson SD
    Biochemistry; 1999 Jun; 38(25):8159-66. PubMed ID: 10387061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The
    Hashemi SA; Kyani A; Bathaie SZ
    J Biomol Struct Dyn; 2022 Nov; 40(18):8274-8285. PubMed ID: 33879035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.